4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-phenyl-2-N-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine
C26H23N7O — CID 11561456
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-phenyl-2-N-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine
4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-phenyl-2-N-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine (PubChem CID 11561456) has the molecular formula C26H23N7O and a molecular weight of 449.52 g/mol. Its IUPAC name is 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-phenyl-2-N-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine.
Molecular Properties
| Compound Name | 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-phenyl-2-N-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine |
|---|---|
| PubChem CID | 11561456 |
| Molecular Formula | C26H23N7O |
| Molecular Weight | 449.52 g/mol |
| Exact Mass | 449.20 |
| IUPAC Name | 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-phenyl-2-N-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine |
| SMILES | c1ccc(-c2cc(CNc3nc(Nc4cc(C5CC5)[nH]n4)cc(-c4ccccc4)n3)on2)cc1 |
| InChI | InChI=1S/C26H23N7O/c1-3-7-17(8-4-1)21-14-24(29-25-15-22(31-32-25)19-11-12-19)30-26(28-21)27-16-20-13-23(33-34-20)18-9-5-2-6-10-18/h1-10,13-15,19H,11-12,16H2,(H3,27,28,29,30,31,32) |
| InChIKey | RTUDMMLXMCPWTJ-UHFFFAOYSA-N |
| XLogP | 5.75 |
| TPSA | 104.55 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.52 |
| LogP ≤ 5 | 5.75 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11561456 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.